FDA Investigator Nancy L Rolli
Nancy L Rolli has inspections in 6 countries as of 22 Sep 2023. Nancy L Rolli has collaborated with a combinined 3464 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
40
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Germany,
France,
United Kingdom of Great Britain and Northern Ireland,
Canada
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Alberto A Viciedo,
Allen Lou,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Ana S Cabrera,
Ann Marie Montemurro,
Annemarie B Randow,
Annemarie Bodnar,
Annet R Rajan,
Anthony J Donato,
Arie C Menachem,
Arsen Karapetyan,
Atul J Agrawal,
Barbara J Maulfair,
Barbara J Wilimczyk,
Barbara Jwilimczyk Macri,
Barbara L Rellahan, PhD,
Bei Yu,
Benjamin J Smith,
Bijoy Panicker,
Brian J Ryan,
Brian S Keefer,
Bruce H Mccullough,
Byungja E Marciante,
Cara M Minelli,
Carla J Lundi,
Carr Sharpe,
Caryn M Mcnab,
Charles L Zhou,
Christina P Burkhart,
Constantin Y Philopoulos,
Cynthia F Kleppinger, MD,
Daniel J Grabicki,
David A Oluwo,
Dawn L Wydner,
Deborah B Nixon,
Dennis Cantellops Paite,
Donald L Lech,
Donna Mwilliams Hill,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Edward D Mcdonald,
Edwin Melendez,
Emest F Bizjak,
Emmanuel J Ramos,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Esteban Beltran,
Frank J Marciniak,
Fred Razzaghi,
Frederick Razzaghi,
Gayle S Lawson,
Ginger M Sykes,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
Ifueko Osemwota,
Ivan E Reyes,
Jacqueline Mdiaz Albertini,
James R Birkenstamm,
Jamie M Du,
Jane S Wernberg,
Jean Blackston Hill,
Jean M Kelahan,
Jean M Mulinde, MD,
Jeffrey D Meng,
Jeffrey J Ebersole,
Jennifer M Gogley,
Joanne Heim,
Joel D Hustedt,
Joey V Quitania,
John A Gonzalez,
Jonee J Mearns,
Jose Acruz Gonzalez,
Joseph A Piechocki,
Joseph F Mcginnis, RPh,
Joshua P Wireman,
Joy R Kelna,
Joy Rkozlowski Klena,
Julie A Rorberg,
Julie A Stocklin,
Julie D Bringger,
Justine M Corson,
Karen E D'orazio,
Katherine D Adams,
Katherine E Jacobitz,
Keith M Reilly,
Kelli F Dobilas,
Kenneth H Williams,
Kenneth M Gordon,
Kevin A Gonzalez,
Kevin D Kallander,
Kham Phommachanh,
Kim Lthomas Cruse,
Kinh Q Mac,
Kristy A Zielny,
Kumar G Janoria,
Larry K Austin,
Laura Fontan, MS,
Lauren L Vajo,
Li Li,
Liatte Kreuger, PharmD,
Liming Zhang,
Linda K Cline,
Linda Thai,
Lisa B Hall,
Lisa M Bellows,
Louis B Cencetti,
Lydia Irosas Marty,
Marcus F Yambot,
Marea K Harmon,
Margaret M Annes,
Margaret M Sands,
Maria Estrella,
Mark R Mcclain,
Matthew A Spataro,
Matthew B Casale,
Matthew J Johnson,
Matthew Sparato,
Maya M Davis,
Melba T Rivera,
Melba Trivera Clavell,
Melissa D Ray,
Meredith L Sheridan,
Meyer J Slobotsky,
Michael A Charles,
Michael P Sheehan,
Michael R Goga,
Michael R Klapal,
Michael Serrano,
Michael W Burd,
Michele L Obert,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Mra M Barbosar,
Mra Munizn,
Nancy A Saxenian,
Nancy A Saxenian Emmons,
Nancy G Schmidt,
Nancy M Espinal,
Nancy Roll,
Nicholas A Violand,
Niketa Patel,
Nina Yang,
Niraj Mehta,
Parul M Patel,
Patrick C Klotzbuecher,
Paul L Bellamy,
Paul Mouris,
Peter R Lenahan,
Philip F Istafanos, DMV, MS,
Prabhu P Raju,
Qin Xu,
Rebecca E Dombrowski,
Regina T Brown,
Robert M Barbosa,
Rochelle K Kimmel,
Russell J Glapion,
Saied A Asbagh,
Samantha J Bradley,
Sandra Kershaw,
Sanket N Patel,
Sarah Adella Fave,
Shirley H Isbill,
Shirley S Wen,
Shirnette D Ferguson,
Sidney B Priesmeyer,
Sinai Davis,
Sripal R Mada, PhD,
Stephen J Mottola,
Sue Lee Chan,
Susanna E Ford, Analyst,
Tajah L Blackburn,
Tamil Arasu, PhD,
Tara G Bizjak,
Tara R Gooen,
Terri L Dodds,
Thao T Kwan,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy T Kapsala,
Valerie C Reed,
Virgilio F Pacio, CSO,
Vlada Matusovsky,
Wayne E Seifert,
Wayne J Meyer,
William Chang,
William R Chang,
Xikui Chen (nmi), PhD,
Yasamin Ameri,
Yumi J Hiramine,
Yvins Dezan,
Zachary A Bogorad
Nancy L Rolli's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more